American journal of hematology,
Apr 2024
DOI: 10.1002/ajh.27306
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study
Groh, Matthieu ;
Fenwarth, Laurène ;
Labro, Mathilde ;
Boudry, Augustin ;
Fournier, Elise ;
Wemeau, Mathieu ;
Marceau-Renaut, Alice ;
Daltro de Oliveira, Rafael ;
Abraham, Julie ;
Barry, Marly ;
Blanche, Philippe ;
Bodard, Quentin ;
Braun, Thorsten ;
Chebrek, Safia ;
Decamp, Matthieu ;
Durel, Cécile-Audrey ;
Forcade, Edouard ;
Gerfaud-Valentin, Mathieu ;
Golfier, Camille ;
Gourguechon, Clément ;
Grardel, Nathalie ;
Kosmider, Olivier ;
Martis, Nihal ;
Melboucy Belkhir, Sarah ;
Merabet, Fatiha ;
Michon, Adrien ;
Moreau, Stéphane ;
Morice, Cécile ;
Néel, Antoine ;
Nicolini, Franck E ;
Pascal, Laurent ;
Pasquier, Florence ;
Pieragostini, Andrea ;
Roche-Lestienne, Catherine ;
Rousselot, Philippe ;
Terriou, Louis ;
Thiebaut-Bertrand, Anne ;
Viallard, Jean-François ;
Preudhomme, Claude ;
Kahn, Jean-Emmanuel ;
Lefevre, Guillaume ;
Duployez, Nicolas ;
CEREO Collaborators,
Show All
PRODUCTS USED
Variant Libraries
Read Full
Article
ABSTRACT
We investigated using a custom NGS panel of 149 genes the mutational landscape of 64 consecutive adult patients with tyrosine kinase fusion-negative hypereosinophilia (HE)/hypereosinophilic syndrome (HES) harboring features suggestive of myeloid neoplasm. At least one mutation was reported in 50/64 (78%) patients (compared to 8/44 (18%) patients with idiopathic HE/HES/HEUS used as controls; p